Home Boronic acids Pyridine-4-boronic acid

Pyridine-4-boronic acid

CAS No.:
1692-15-5
Catalog Number:
AG001YKP
Molecular Formula:
C5H6BNO2
Molecular Weight:
122.9176
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
97%
In Stock USA
United States
$13
- +
5g
97%
In Stock USA
United States
$18
- +
25g
97%
In Stock USA
United States
$55
- +
100g
97%
In Stock USA
United States
$188
- +
500g
97%
In Stock USA
United States
$850
- +
Product Description
Catalog Number:
AG001YKP
Chemical Name:
Pyridine-4-boronic acid
CAS Number:
1692-15-5
Molecular Formula:
C5H6BNO2
Molecular Weight:
122.9176
MDL Number:
MFCD08061353
IUPAC Name:
pyridin-4-ylboronic acid
InChI:
InChI=1S/C5H6BNO2/c8-6(9)5-1-3-7-4-2-5/h1-4,8-9H
InChI Key:
QLULGIRFKAWHOJ-UHFFFAOYSA-N
SMILES:
OB(c1ccncc1)O
Properties
Complexity:
83  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
123.049g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
122.918g/mol
Monoisotopic Mass:
123.049g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
53.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors. Journal of medicinal chemistry 20120322
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design. Journal of medicinal chemistry 20120308
Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes. PloS one 20120101
Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors. The Journal of organic chemistry 20111104
trans-Dichloridobis[(pyridin-4-yl)boronic acid-κN]palladium(II) dimethyl sulfoxide disolvate. Acta crystallographica. Section E, Structure reports online 20110501
Synthesis, carbohydrate- and DNA-binding studies of cationic 2,2':6',2''-terpyridineplatinum(II) complexes containing N- and S-donor boronic acid ligands. Dalton transactions (Cambridge, England : 2003) 20110114
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds. Bioorganic & medicinal chemistry 20100915
Metal-free carbon-carbon bond-forming reductive coupling between boronic acids and tosylhydrazones. Nature chemistry 20090901
An experimental and theoretical study of molecular structure and vibrational spectra of 3- and 4-pyridineboronic acid molecules by density functional theory calculations. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080801
Synthesis and preliminary DNA-binding studies of diimineplatinum(II) complexes containing 3- or 4-pyridineboronic acid. Dalton transactions (Cambridge, England : 2003) 20070607
A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. Journal of neuroinflammation 20070101
N-alkyl-4-boronopyridinium salts as thermally stable and reusable amide condensation catalysts. Organic letters 20051027
N-alkyl-4-boronopyridinium halides versus boric acid as catalysts for the esterification of alpha-hydroxycarboxylic acids. Organic letters 20051027
A molecular box derived from cobaloxime units held together by 4-pyridinylboronic acid residues. Inorganic chemistry 20011022
Properties